This Webinar will explain what 21 CFR Part 11 is? Why it is important for FDA regulated companies? and how conformance to Part 11 differs from just having good IT security? Procedures for controlling electronic signatures and electronic records as described in the FDA Guidance will be explained.
FDA regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being compromised with possible resulting harm to the patient.
FDA has set up regulations that address both data security and patient safety. We will show how 21 CFR part 11 considers both. The confusion over the original FDA regulation and its subsequent “selective enforcement” will be explained. FDA requirements for 21CFR Part 11 validation will be explained. The requirements are composed of technical and procedural aspects. Open, closed and hybrid (paper and electronic) systems will also be explained.
Companies want to transition to electronic records but are afraid of compromising their quality system and receiving 483’s at their next inspection. Part of this fear originates from confusion. FDA originally published a rather severe 21 CFR Part 11. After industry complaints, the FDA acknowledged that the regulation, as written, would result in nobody attempting to convert to electronic records. However, instead of rewriting the regulation, FDA said it would “selectively enforce” sections of the regulation. This webinar will explain what all this means. A 21CFR checklist and a Test protocol form will be given as hangouts.
Origin of the regulation and changes in interpretation; electronic records; electronic signatures; data security; open, closed and hybrid systems; validation methods; risk analysis.
Companies want to transition to electronic records but are afraid of compromising their quality system and receiving 483’s at their next inspection. Part of this fear originates from confusion. FDA originally published a rather severe 21 CFR Part 11. After industry complaints, the FDA acknowledged that the regulation, as written, would result in nobody attempting to convert to electronic records. However, instead of rewriting the regulation, FDA said it would “selectively enforce” sections of the regulation. This webinar will explain what all this means. A 21CFR checklist and a Test protocol form will be given as hangouts.
Origin of the regulation and changes in interpretation; electronic records; electronic signatures; data security; open, closed and hybrid systems; validation methods; risk analysis.
Edwin Waldbusser
Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Re-imagine Finance & Accounting Made Simple. Three Webinars…
Transforming Change and Conflict into Diverse-Inclusive-Col…
New EEOC Report: Workplace Harassment Prevention Not Workin…
Human Error Reduction Techniques for Floor Supervisors
21 CFR Part 11 - Compliance for Electronic Records and Sign…
Form W-9 Compliance to Avoid Penalties: TIN Verification, B…
Future Of Forecasting And Budgeting With Rolling Forecast
Managing Difficult Employee Conversations
Navigating 2025 Employment Laws: What Every Employer Needs …
ChatGPT and Project Management: Leveraging AI for Project M…
Handbook Overhaul 2026: Compliance, OBBB Act & Beyond
Excel Power Skills: Master Functions, Formulas, and Macros …
Internal Controls in Accounts Payable
The FMLA - An Employer's Guide to Compliance and Employee A…
Develop People Intelligence: Is Your Communication Style as…
The Impact of Artificial Intelligence on Your Workforce
AI in Everyday Work – help with Microsoft products
How to Document Employee Discussions and Why it is Important
Construction Lending And Real Credit Administration: Evalua…
2025 EEOC & Employers: Investigating Claims of Harassment …
Navigating FDA Inspections: From SOP to 483
2-Hour Virtual Seminar on DeepSeek R1 for Business and Mark…
The Anti-Kickback Statute: Enforcement and Recent Updates
Risk Analysis in the Medical Device Design Process
Introduction to Microsoft Power BI Dashboards
How To Get Control of Your Day, Life & Career - Time Manage…
AI Across the Business: Practical Use Cases for Founders an…
Female to Female Hostility @Workplace: All you Need to Know
Writing Effective 483 and Warning Letter Responses
6-Hour Virtual Seminar on Learning the Highlights of Excel …
FDA Recommendations for Artificial Intelligence/Machine Lea…
Do's and Don'ts of Giving Effective Feedback for Performanc…
Writing Techniques for Auditors and Risk Management Profess…
Retention Starts Here: Stop Losing Your Critical Talent and…
Gossip-Free: Leadership Techniques to Quell Office Chatter
Language is Code - Intro to AI - Generative AI - ChatGPT an…
Understanding EBITDA – Definition, Formula & Calculation